Factors Affecting the Speed of Recovery After ACL Reconstruction
Launched by UNIVERSITY OF WASHINGTON · Dec 6, 2018
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
Anterior cruciate ligament (ACL) tears of the knee are frequently repaired by surgically implanting a tendon graft in place of the torn original cruciate ligament. The graft may be taken from the patient having the repair (an autologous graft) or from a cadaver (an allograft). Complete recovery from surgical repair of an anterior cruciate ligament reconstruction requires that the graft becomes firmly engrafted at the site, surrounding tissues are healed and strength is restored in muscles that control movements at the knee. The recovery process typically requires from six months to one year...
Gender
ALL
Eligibility criteria
- INCLUSION Criteria:
- • Subjects must be age 18-65,
- • Subjects must be undergoing ACL repair at UWMC
- • Subjects must be between an anesthesia risk category of 1-3
- • Subjects must be candidates to have a nerve block if they should choose so.
- • Subjects must be free of neurologic disease or coagulation defects
- • Subjects must have no allergies to typical medications used during nerve blocks.
- • Subjects must be fluent in English, able to read, and understand English readily in person or and/over the phone.
- EXCLUSION Criteria:
- • Any patients under 18 or over 75
- • Patients with a BMI in excess of 40
- • Non-English speaking patients
- • Patients with allergies to nerve block medications
- • Patients with neurological disease or coagulation defects
- • Patients not undergoing ACL repair at UWMC
- • Patients who are opioid tolerant
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials